Schedule 13G ownership disclosure

MARINUS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 56854Q101

Event date: 2019-09-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,002,840
Percent of class
7.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-19-053242
Form type
SC 13G
Filer
MARINUS PHARMACEUTICALS, INC.
CIK
CIK 1267813
Filed
Oct 07, 2019
Reporting period
Sep 26, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub